How does international regulation differ from that in the United States?
International regulation of cancer treatments varies, but most countries have their own agencies similar to the FDA. The EMA, for example, oversees the approval of new drugs in the European Union. While the regulatory processes are similar, there can be differences in approval times and specific requirements, which can affect the availability of treatments.
